5 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 8 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 8 | Completed 5, Enrolling by invitation 1, Recruiting 1, Terminated 1 |
Follow Solutions: new trials by email Literature Review of Solutions trials Research Report on Solutions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity ZP6590, solution for injection, Placebo, solution for injection - Healthy Participants Study, Overweight and Obese Adults | Early Phase 1 | Recruiting | Zealand Pharma | 88 | 2026-07-09 | 2026-08-13 |
| Handheld MPI Imaging to Track Stem Cells in Osteoarthritis Human Umbilical Cord-derived Mesenchymal Stromal Cells (hUC-MSCs), Ferumoxytol (SPIO) Solution for Injection (Placebo) - Knee Arthritis Osteoarthritis | Early Phase 1 | Enrolling by invitation | Soochow University | 10 | 2025-12-16 | 2026-05-12 |
| Ridge Preservation With FDBA (Freeze Dried Bone Allograft) Using Dexamethasone vs. Saline Dexamethasone 4mg/ml solution - Bone Graft, Tooth Extraction | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 44 | 2024-09-16 | 2026-01-22 |
| IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy Omnipaque 300mg/mL Solution for Injection, Cone Beam CT, Radiation Therapy - Pelvic Cancer, Abdominal Cancer | Early Phase 1 | Terminated | Columbia University | 6 | 2020-10-01 | 2024-05-31 |
| Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults Octreotide, Insulin, Dextrose 20% solution - Vascular Stiffness, Insulin Sensitivity | Early Phase 1 | Completed | University of Virginia | 15 | 2019-02-04 | 2022-05-13 |
| AvenovaTM as a Sterile Skin Preparation Agent Avenova, Povidone-iodine 5% solution, 4% chlorhexidine - Cleaning Product Causing Toxic Effect | Early Phase 1 | Completed | University of Miami | 21 | 2018-12-01 | 2020-02-05 |
| Evaluation of Bioavailability of Diclofenac Dermal Products Diclofenac Epolamine Patch, diclofenac sodium solution - Bioavailability | Early Phase 1 | Completed | University of Maryland, Baltimore | 12 | 2017-04-19 | 2020-06-30 |
| Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia Topical gabapentin - Scarring Alopecia, Frontal Fibrosing Alopecia | Early Phase 1 | Completed | University of Minnesota | 5 | 2016-01-28 | 2024-03-25 |
Alopecia (1) · Insulin Resistance (1) · Lichen Planus (1) · Obesity (1) · Overweight (1) · Pelvic Neoplasms (1)
Columbia University (1) · Soochow University (1) · The University of Texas Health Science Center at San Antonio (1) · University of Maryland, Baltimore (1) · University of Miami (1) · University of Minnesota (1) · University of Virginia (1) · Zealand Pharma (1)
United States (6) · China (1) · Germany (1)
Audra L Stinchcomb, PhD (1) · Brian L Mealey, DDS, MS (1) · David Horowitz, MD (1) · Hazem E Hassan, PhD (1) · Maria K Hordinsky, MD (1) · Tuo Shao (1) · Wendy Lee (1)
T32DK007646 (1)